{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:11:58Z","timestamp":1789171918277,"version":"build-2803163510"},"reference-count":15,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Dermatology"],"published-print":{"date-parts":[[2026,10]]},"abstract":"ABSTRACT<\/jats:title>\n \n Background<\/jats:title>\n Rush immunotherapy (RIT) accelerates the induction phase of allergen\u2010specific immunotherapy treatment (ASIT) by administering incrementally increasing allergen doses over a single day. This approach reduces the time required to maintenance dosing. Safety information in cats with atopic skin syndrome (FASS) remains limited.<\/jats:p>\n <\/jats:sec>\n \n Hypothesis\/Objectives<\/jats:title>\n The objective of the study was to evaluate the safety of RIT in cats with hypersensitivity disease compatible with FASS and to describe the frequency and nature of adverse events.<\/jats:p>\n <\/jats:sec>\n \n Animals<\/jats:title>\n Forty\u2010seven client\u2010owned cats that underwent RIT.<\/jats:p>\n <\/jats:sec>\n \n Materials and Methods<\/jats:title>\n A multicentre medical record review from 2019 to 2024 was performed to identify cats that met at least six of 10 criteria for non\u2010flea\u2010induced hypersensitivity dermatitis and were therefore considered consistent with a diagnosis of FASS. All included cats received documented flea prevention and underwent elimination diet trials. Data collected included signalment, medical history, concurrent medications, RIT protocol details, monitoring findings and follow\u2010up communication. Adverse events (AEs) were recorded.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n In three of 47 cats (6.4%), AEs were observed including tachypnoea, behavioural distress and increased pruritus. In one cat, RIT was discontinued before protocol completion. All affected cats transitioned to maintenance ASIT without recurrence of AEs.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Clinical Relevance<\/jats:title>\n Rush immunotherapy appears to be safe in cats with FASS when performed with clinical monitoring. Adverse events were infrequent, mild and self\u2010limiting, supporting use of accelerated induction protocols in appropriately selected patients.<\/jats:p>\n <\/jats:sec>","DOI":"10.1111\/vde.70108","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T14:54:34Z","timestamp":1785509674000},"page":"729-734","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Retrospective Review of Rush Allergen\u2010Specific Immunotherapy Safety in Cats With Atopic Skin Syndrome"],"prefix":"10.1111","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8467-5311","authenticated-orcid":false,"given":"A.","family":"Wirkkala","sequence":"first","affiliation":[{"name":"Animal Dermatology Clinic, Southern California Tustin California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1616-8261","authenticated-orcid":false,"given":"W.","family":"Rosenkrantz","sequence":"additional","affiliation":[{"name":"Animal Dermatology Clinic, Southern California Tustin California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Mendelsohn","sequence":"additional","affiliation":[{"name":"Animal Dermatology Clinic, Southern California Tustin California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Griffin","sequence":"additional","affiliation":[{"name":"Animal Dermatology Clinic Las Vegas Nevada USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Schaufele","sequence":"additional","affiliation":[{"name":"Animal Dermatology Clinic Perth Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Burrows","sequence":"additional","affiliation":[{"name":"Animal Dermatology Clinic Perth Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"e_1_2_9_2_1","first-page":"1237","article-title":"Feline Atopic Syndrome \u2013 An Update","volume":"62","author":"Bajwa J.","year":"2021","journal-title":"Canadian Veterinary Journal"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1177\/1098612X13500427"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3164.2011.01006.x"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/vde.12935"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/vde.12899"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cvsm.2018.08.001"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.2460\/javma.22.12.0576"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/vde.12892"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3164.2005.00462.x"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/vec.12066"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-0813.2006.tb12768.x"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/vde.13170"},{"key":"e_1_2_9_14_1","article-title":"Rush Immunotherapy in Two Cats With Atopic Skin Syndrome","volume":"7","author":"Jones S.","year":"2021","journal-title":"JFMS Open Reports"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetimm.2005.09.013"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2024.100876"}],"container-title":["Veterinary Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/vde.70108","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/vde.70108","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/vde.70108","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:30:41Z","timestamp":1789169441000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/vde.70108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1111\/vde.70108"],"URL":"https:\/\/doi.org\/10.1111\/vde.70108","archive":["Portico"],"relation":{},"ISSN":["0959-4493","1365-3164"],"issn-type":[{"value":"0959-4493","type":"print"},{"value":"1365-3164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"assertion":[{"value":"2026-03-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}